As healthcare professionals, staying informed about the latest advancements in disease management is crucial. Epilepsy, a neurological disorder marked by sudden recurrent episodes of sensory disturbance, is one such condition that has seen significant progress in recent years. This article aims to provide a comprehensive update on the recent advances in epilepsy management.
Several new AEDs have been approved by the FDA in recent years, offering more options for patient care. These include cenobamate for the treatment of partial-onset seizures, and fenfluramine for Dravet syndrome. These drugs have shown promising results in clinical trials, improving seizure control and tolerability.
Surgical procedures for epilepsy have also evolved, with minimally invasive techniques such as laser ablation therapy becoming more prevalent. This approach allows for precise targeting of seizure foci, reducing the risk of damage to surrounding healthy brain tissue.
Neuromodulation devices like vagus nerve stimulators, responsive neurostimulation systems, and deep brain stimulation systems have shown promise in reducing seizure frequency and severity. These devices provide an alternative for patients who are not responsive to AEDs or are not suitable candidates for surgery.
Genetic testing has emerged as a valuable tool in epilepsy management. It can help identify the underlying genetic cause of epilepsy in some patients, enabling personalized treatment plans and potentially improving outcomes.
In conclusion, the field of epilepsy management is evolving rapidly, with advances in pharmacological treatments, surgical procedures, neuromodulation devices, and genetic testing. These developments offer new hope for patients and challenges for healthcare professionals to stay updated. It is essential for healthcare professionals to continue learning and adapting to provide the best possible care for their patients with epilepsy.
1.
AI-based liquid biopsy shows promise for detecting brain cancer
2.
To refute accusations that it failed to issue a cancer warning, Roundup's maker is asking lawmakers for assistance.
3.
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
4.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
5.
Males with early-onset colorectal cancer are at risk, according to a study.
1.
Advances in Cancer Detection: From Genetic Risk to Molecular Biomarkers
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
Innovative Breakthroughs in Hematology for Modern Medicine
5.
Precision Erythropoietic Modeling for Hematologic Disorders
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Role of Screening in Cancer Prevention
2.
Innovations in Hematology
3.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
4.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation